CoChat

Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy

Open access
Fux, Alexandra C., Casonato Melo, Cristiane, Michelini, Sara, Swartzwelter, Benjamin J., Neusch, Andreas, Italiani, Paola, Himly, Martin · 2023 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 227 of the 228 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Lipopolysaccharide (LPS), also referred to as endotoxin, is the major component of Gram-negative bacteria’s outer cell wall. It is one of the main types of pathogen-associated molecular patterns (PAMPs) that are known to elicit severe immune reactions in the event of a pathogen trespassing the epithelial barrier and reaching the bloodstream. Associated symptoms include fever and septic shock, which in severe cases, might even lead to death. Thus, the detection of LPS in medical devices and injectable pharmaceuticals is of utmost importance. However, the term LPS does not describe one single molecule but a diverse class of molecules sharing one common feature: their characteristic chemical structure. Each bacterial species has its own pool of LPS molecules varying in their chemical composition and enabling the aggregation into different supramolecular structures upon release from the bacterial cell wall. As this heterogeneity has consequences for bioassays, we aim to examine the great variability of LPS molecules and their potential to form various supramolecular structures. Furthermore, we describe current LPS quantification methods and the LPS-dependent inflammatory pathway and show how LPS heterogeneity can affect them. With the intent of overcoming these challenges and moving towards a universal approach for targeting LPS, we review current studies concerning LPS-specific binders. Finally, we give perspectives for LPS research and the use of LPS-binding molecules.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms24098395

Cites

227 of 228 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure A1 Structures of lipid A from different bacterial species. References to structures are listed in Table 1. Possible variations of the structures are marked in red.
Figure A1 Structures of lipid A from different bacterial species. References to structures are listed in Table 1. Possible variations of the structures are marked in red.CC BY · PubMed Central
Figure 1 Schematic illustration of the LPS structure. LPS shown in bright red is anchored in the outer membrane of (G-) bacteria. Smooth- (S), semi-rough- (SR), rough- (R) or deep-rough- (DR) LPS types are defined by the length of the O-antigen and core region. The variability decreases from the outermost part of LPS to the hydrophobic innermost part. Different sugar moieties are shown in blue and green; heptose is shown in yellow; 3-deoxy-D-manno-octulosonic acid (KDO) in orange, and glucosamine (I and II) in gray.
Figure 1 Schematic illustration of the LPS structure. LPS shown in bright red is anchored in the outer membrane of (G-) bacteria. Smooth- (S), semi-rough- (SR), rough- (R) or deep-rough- (DR) LPS types are defined by the length of the O-antigen and core region. The variability decreases from the outermost part of LPS to the hydrophobic innermost part. Different sugar moieties are shown in blue and green; heptose is shown in yellow; 3-deoxy-D-manno-octulosonic acid (KDO) in orange, and glucosamine (I and II) in gray.CC BY · PubMed Central
Figure 2 Overview of the main challenges in endotoxin quantification. The chemical variability of LPS, supramolecular structures, and interaction with molecules result in inaccurate and/or unreproducible endotoxin quantification measurements.
Figure 2 Overview of the main challenges in endotoxin quantification. The chemical variability of LPS, supramolecular structures, and interaction with molecules result in inaccurate and/or unreproducible endotoxin quantification measurements.CC BY · PubMed Central
Figure 3 Scheme of the most relevant pathways for LPS detection in human cells. Left: detection of intracellular LPS via caspase proteins causes the assembly of a supramolecular complex called inflammasome, which induces the initiation of the potent inflammatory process called pyroptosis. Right: detection of extracellular LPS via the TLR4 receptor complex and initiation of inflammatory responses via the MyD88 and TRIF signaling cascades.
Figure 3 Scheme of the most relevant pathways for LPS detection in human cells. Left: detection of intracellular LPS via caspase proteins causes the assembly of a supramolecular complex called inflammasome, which induces the initiation of the potent inflammatory process called pyroptosis. Right: detection of extracellular LPS via the TLR4 receptor complex and initiation of inflammatory responses via the MyD88 and TRIF signaling cascades.CC BY · PubMed Central
Figure 4 Schematic representation of Yersinia pestis life cycle with focus on how the lipid A moiety changes during the different stages, ultimately interfering in the host’s immune response. The top part of the image shows the life cycle in wild animals. Briefly, Yersinia pestis-infected fleas bite wild rodents and transmit the pathogen. Triggered by the rodent’s body temperature of 37 °C, it starts producing a less immunogenic variant of lipid A (tetra-acylated), which is not able to elicit an effective immune response. As a result, Yersinia pestis is not fully eliminated and persists. The rodent becomes a reservoir of the pathogen in the wild and can, in turn, infect vector fleas, which feed on their blood. Once Yersinia pestis reaches the flea digestive tract (27 °C), it produces a hexa-acylated form of lipid A and starts proliferation in these favored conditions. By biting a new host, the flea can further spread the disease. Once humans are accidentally bitten (bottom part of the figure), the bacterium produces the tetra-acylated form of lipid A again to adapt to the human body temperature. However, in contrast to rodent TLR4, the human TLR4 does not recognize this lipid A variant, and therefore, it is not able to activate the downstream signaling cascade. As a result, the immune response is ineffective as it has to rely only on other defense mechanisms. Yersinia pestis invades the body undisturbed, causing a disease called plague.
Figure 4 Schematic representation of Yersinia pestis life cycle with focus on how the lipid A moiety changes during the different stages, ultimately interfering in the host’s immune response. The top part of the image shows the life cycle in wild animals. Briefly, Yersinia pestis-infected fleas bite wild rodents and transmit the pathogen. Triggered by the rodent’s body temperature of 37 °C, it starts producing a less immunogenic variant of lipid A (tetra-acylated), which is not able to elicit an effective immune response. As a result, Yersinia pestis is not fully eliminated and persists. The rodent becomes a reservoir of the pathogen in the wild and can, in turn, infect vector fleas, which feed on their blood. Once Yersinia pestis reaches the flea digestive tract (27 °C), it produces a hexa-acylated form of lipid A and starts proliferation in these favored conditions. By biting a new host, the flea can further spread the disease. Once humans are accidentally bitten (bottom part of the figure), the bacterium produces the tetra-acylated form of lipid A again to adapt to the human body temperature. However, in contrast to rodent TLR4, the human TLR4 does not recognize this lipid A variant, and therefore, it is not able to activate the downstream signaling cascade. As a result, the immune response is ineffective as it has to rely only on other defense mechanisms. Yersinia pestis invades the body undisturbed, causing a disease called plague.CC BY · PubMed Central
Figure 5 Graphical scheme depicting the underlying mechanisms in different LPS detection methods. From left to right: rabbit pyrogen test (RPT), monocyte activation test (MAT), gel clot limulus amebocyte lysate (LAL) assay and its variants (e.g., chromogenic LAL), EndoLISA, and, ultimately, the TLR4-NF-κB-luciferase (TLR4-NF-κB-luc) reporter gene assay.
Figure 5 Graphical scheme depicting the underlying mechanisms in different LPS detection methods. From left to right: rabbit pyrogen test (RPT), monocyte activation test (MAT), gel clot limulus amebocyte lysate (LAL) assay and its variants (e.g., chromogenic LAL), EndoLISA, and, ultimately, the TLR4-NF-κB-luciferase (TLR4-NF-κB-luc) reporter gene assay.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 228 references

Research works printed but not linked: 8

  1. Kolmos, 2006, Panum’s Studies on “Putrid Poison” 1856, Dan. Med. Bull., 53, 450
  2. Williams, K.L. (2019). Discovery and Early Development of the Limulus Test, Springer International Publishing.
  3. Loverock, 2010, A Recombinant Factor C Procedure for the Detection of Gram-Negative Bacterial Endotoxin, United States Pharmacop. Conv.-Pharmacop. Forum, 36, 321
  4. Dawson, 1993, Endotoxin Standards and CSE Potency, LAL Updat., 11, 1
  5. Tsuchiya, 2014, Possible Mechanism of Low Endotoxin Recovery, Am. Pharm. Rev., 17, 1
  6. Meadows, 2018, Aseptic Sampling Best Practices Endotoxin Binding Affinity, Sartorius, SP-4006-e, 1
  7. Novitsky, 1988, The Problems with Plastics, Lal Update, 6, 1
  8. (2023, February 12). PubMed Keyword “Endotoxin” 5203 Events, Keyword “Lipopolysaccharide” 7853 Events, Available online: https://pubmed.ncbi.nlm.nih.gov/.

Cited by

See all 83

Metadata

Authors
Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M.
Affiliations
  • Miltenyi Biotec (Germany) (DE)
  • Division of Allergy & Immunology, Department of Biosciences & Medical Biology, Paris Lodron University of Salzburg (PLUS), Hellbrunnerstraße 34, 5020 Salzburg, Austria
  • University of Ljubljana (SI)
  • Colorado State University (US)
  • Heinrich Heine University Düsseldorf (DE)
  • Stazione Zoologica Anton Dohrn (IT)
  • University of Salzburg (AT)
Corresponding author
Himly, Martin
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2023-05-07
Volume
24
Issue
9
Pages
8395
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4375862682
Cited by
83
References
225
Citations by year
2026: 27 · 2025: 24 · 2024: 26 · 2023: 6
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
Funders
  • European Union’s Horizon 2020 research and innovation programme (H2020-MSCA-ITN-2018-812661, 890610)
  • Austrian Research Promotion Agency (FFG) (H2020-MSCA-ITN-2018-812661, 890610)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
lipopolysaccharide, endotoxin, LPS-binding protein, Gram-negative bacteria, pathogen-associated molecular patterns, septic shock
MeSH terms
Biological Assay, Endotoxins, Humans, Lipopolysaccharides, Shock, Septic, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy. https://app.cochat.ai/papers/10.3390/ijms24098395
The paper
Fux, A. C., Casonato Melo, C., Michelini, S., Swartzwelter, B. J., Neusch, A., Italiani, P., & Himly, M. (2023). Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098395

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.